Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (181-190 of 357) with videos related to

Pageof 36
Sort By:
Critical Reviews in Oncology/Hematology|July 18, 2008
Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future developmentCesare Guida, Paolo Maione, Antonio Rossi, et al.
Clinical Lung Cancer|January 12, 2008
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamicsCesare Gridelli, Antonio Rossi, Floriana Morgillo, et al.
Cancers|June 25, 2020
Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)Nicola Normanno, Massimo Barberis, Filippo De Marinis, et al.
Expert Review of Anticancer Therapy|October 21, 2015
Agents in the preclinical development stage for non-small cell lung cancerPaola Claudia Sacco, Assunta Sgambato, Francesca Casaluce, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Expert Opinion on Pharmacotherapy|August 2, 2013
Medical treatment of small cell lung cancer: state of the art and new developmentAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 30, 2016
Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC)Cesare Gridelli, Andrea Camerini, Giovanni Pappagallo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment studyMartin Reck, Nico van Zandwijk, Cesare Gridelli, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Screening for lung cancer: New horizons?Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Expert Opinion on Pharmacotherapy|October 13, 2007
Erlotinib in non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Pageof 36

Showing results (181-190 of 357) with videos related to

Sort By:
Pageof 36
Critical Reviews in Oncology/Hematology|July 18, 2008
Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future developmentCesare Guida, Paolo Maione, Antonio Rossi, et al.
Clinical Lung Cancer|January 12, 2008
A randomized phase II study of pemetrexed or RAD001 as second-line treatment of advanced non-small-cell lung cancer in elderly patients: treatment rationale and protocol dynamicsCesare Gridelli, Antonio Rossi, Floriana Morgillo, et al.
Cancers|June 25, 2020
Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)Nicola Normanno, Massimo Barberis, Filippo De Marinis, et al.
Expert Review of Anticancer Therapy|October 21, 2015
Agents in the preclinical development stage for non-small cell lung cancerPaola Claudia Sacco, Assunta Sgambato, Francesca Casaluce, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Expert Opinion on Pharmacotherapy|August 2, 2013
Medical treatment of small cell lung cancer: state of the art and new developmentAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 30, 2016
Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC)Cesare Gridelli, Andrea Camerini, Giovanni Pappagallo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment studyMartin Reck, Nico van Zandwijk, Cesare Gridelli, et al.
Critical Reviews in Oncology/Hematology|June 28, 2005
Screening for lung cancer: New horizons?Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, et al.
Expert Opinion on Pharmacotherapy|October 13, 2007
Erlotinib in non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paolo Maione, et al.
Pageof 36